Prevalence and Healthcare Costs of Metabolic Disorders Among Individuals with Schizophrenia Following Initiation of Oral Antipsychotic Therapy
{{output}}
Background/objective: Metabolic disorders are prevalent among the schizophrenia population due to relatively poor access to healthcare, lifestyle factors, genetics, and metabolic side effects associated with antipsychotic treatme... ...
